Related Experiment Video
Updated: Mar 21, 2026
05:37
Single-Molecule Fluorescence Visualization of DNA Polymerase Dynamics at G-Quadruplexes
Published on: April 4, 2025
1.4K
DNA G-quadruplex and its potential as anticancer drug target
Onel Buket1, Lin Clement2, Yang DanZhou3
1Department of Chemistry and Biochemistry, University of Arizona, Tucson, AZ 85721, USA.
Science China. Chemistry
|May 17, 2016
Summary
G-quadruplex structures in DNA and RNA are key to human gene regulation and telomere maintenance. Targeting these structures shows promise for developing novel cancer therapeutics.
Area of Science:
- Biochemistry
- Molecular Biology
- Genetics
Background:
- G-quadruplexes are four-stranded nucleic acid structures found in G-rich sequences.
- These structures have significant biological roles in human telomeres and oncogene promoters.
- G-quadruplexes are potential targets for cancer drug development.
Purpose of the Study:
- To review recent advancements in understanding DNA G-quadruplexes.
- To highlight the structural and functional significance of G-quadruplexes in gene promoters and telomeres.
- To explore opportunities for G-quadruplex-targeted small-molecule drug development.
Main Methods:
- Literature review of laboratory's progress.
- Analysis of structural and functional data of DNA G-quadruplexes.
- Evaluation of therapeutic potential.
Main Results:
- G-quadruplexes are biologically significant in human gene promoters and telomeres.
- These structures can form under physiological conditions.
- G-quadruplexes represent a viable target for novel cancer therapeutics.
Conclusions:
- G-quadruplexes are crucial in fundamental biological processes.
- Targeting G-quadruplexes offers a promising avenue for cancer therapy.
- Further research into G-quadruplex structures and functions can accelerate drug discovery.
Related Concept Videos
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
65
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
65
02:57Targeted Cancer Therapies
9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.1K
00:55DNA Helicases
24.8K
DNA unwinding helicase enzymes are a type of motor protein. Motor proteins can translocate along filaments or polymers using energy generated from ATP hydrolysis. Helicases are involved in all the important cellular processes where DNA unwinding is required, such as DNA replication, repair, recombination, and transcription. They are present in all living organisms, but vary in their structure, function, and mechanism of action. For example, in prokaryotes, DnaB helicase binds and translocates...
24.8K
01:28Inhibitors of Bacterial DNA Synthesis
7
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These...
7
02:56Treatment Resistant Cancers
3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
02:36DNA Damage can Stall the Cell Cycle
10.3K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.3K